Last update 23 Jan 2025

SUNGYI BIO. CO., LTD

Seoul, South Korea
|
www.sungyi.co.kr

Overview

Tags

Other Diseases
Nervous System Diseases
Digestive System Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
COX(Cyclooxygenases)2
A1R x A2aR x Adenosine receptor x COX x PDE1

Related

4
Drugs associated with SUNGYI BIO. CO., LTD
Acetaminophen/Fursultiamine/Anhydrous Caffeine
Target
A1R x A2aR x Adenosine receptor x COX x PDE
Mechanism
A1R agonists [+4]
Active Org.
BASKHANBIOpharma, Inc. [+2]
Originator Org.
SUNGYI BIO. CO., LTD
Active Indication
Common Cold
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
South Korea
First Approval Date10 Dec 2024
Acetaminophen/Magnesium Oxide
Target
COX
Mechanism
COX inhibitors
Active Org.
SUNGYI BIO. CO., LTD
Originator Org.
SUNGYI BIO. CO., LTD
Active Indication
Fever [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
South Korea
First Approval Date15 Nov 2024
Docusate Sodium/Bisacodyl
Target-
Mechanism-
Active Org.
SUNGYI BIO. CO., LTD
Originator Org.
SUNGYI BIO. CO., LTD
Active Indication
Abdomen distended [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
South Korea
First Approval Date11 Nov 2024
100 Clinical Results associated with SUNGYI BIO. CO., LTD
Login to view more data
0 Patents (Medical) associated with SUNGYI BIO. CO., LTD
Login to view more data
100 Deals associated with SUNGYI BIO. CO., LTD
Login to view more data
100 Translational Medicine associated with SUNGYI BIO. CO., LTD
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
4
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free